Post by Merck

Name: The FDA accepted our application for an investigational perioperative treatment for muscle-invasive
Uploaded: 2026-04-20T10:58:44.849Z
Channel: Merck
Description: The FDA accepted our application for an investigational perioperative treatment for muscle-invasive bladder cancer (MIBC), a disease impacting about 30% of patients with #BladderCancer. Together with

2,737,329 followers

The FDA accepted our application for an investigational perioperative treatment for muscle-invasive bladder cancer (MIBC), a disease impacting about 30% of patients with #BladderCancer. Together with Pfizer and Astellas Pharma, we’re focused on improving outcomes for these patients. Learn more: go.merck.com/~wtd

Video Content